BenzingaSeptember 24, 2026 at 6:30 AM NYLast Month
HC Wainwright & Co. Reiterates Buy on AnaptysBio, Maintains $95 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates AnaptysBio (NASDAQ:ANAB) with a Buy and maintains $95 price target.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
